Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond.

Ageitos, Lucía et al.·International journal of molecular sciences·2022·
RPEP-059632022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Venom-derived peptides from South American organisms have diverse biological activities.

Key Numbers

How They Did This

This is a review study summarizing existing research on venom-derived peptides.

Why This Research Matters

Understanding venom peptides can lead to new therapies for diseases that are difficult to treat, such as antibiotic-resistant infections and cancer.

What This Study Doesn't Tell Us

As a review, it does not present new experimental data but summarizes existing literature.

Trust & Context

Original Title:
Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond.
Published In:
International journal of molecular sciences, 23(23) (2022)
Database ID:
RPEP-05963

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05963·https://rethinkpeptides.com/research/RPEP-05963

APA

Ageitos, Lucía; Torres, Marcelo D T; de la Fuente-Nunez, Cesar. (2022). Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond.. International journal of molecular sciences, 23(23). https://doi.org/10.3390/ijms232315437

MLA

Ageitos, Lucía, et al. "Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond.." International journal of molecular sciences, 2022. https://doi.org/10.3390/ijms232315437

RethinkPeptides

RethinkPeptides Research Database. "Biologically Active Peptides from Venoms: Applications in An..." RPEP-05963. Retrieved from https://rethinkpeptides.com/research/ageitos-2022-biologically-active-peptides-from

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.